It is well known that CCR7-expressing cancer cells exhibit high lymphatic invasion ability due to the chemotactic effect of its ligands CCL19 and CCL21 which predominantly expressed in lymphatic endothelial cells [19]. Here, CCL19 is linked to cancer.